Health
Study Identifies Cytokine Target for Treatment-Resistant Hemophilia A – MD Magazine
Elevated B cell activating factor levels in children and adults were associated with the development of FVIII inhibitors, which may lead to FVIII infusion failures….
Findings from a new study shed light on the mechanisms behind patient unresponsiveness to coagulation protein therapy for hemophilia A.
More specifically, investigators note a key target that may lead to treatment failure in up to 30% of patients.
Currently, hemophilia is the most common inherited bleeding disorder, which affects 1 in 10,000 men across the globe. Since patients lack coagulation factor VIII (FVIII), therapies are typically aimed at infusions to replace the missing protein.
Some patients,…
-
General9 hours agoQantas terminal at Melbourne Airport evacuated and flights delayed due to fire
-
Noosa News24 hours agoQueensland’s ‘promising’ coercive control laws see more than 50 charges laid in six months since criminalisation
-
General23 hours agoCool weather sets cherry crops ‘weeks’ behind schedule in lead-up to Christmas
-
Noosa News21 hours agoFormer Townsville mayor Troy Thompson found to have lied about military service, tertiary education and cancer